Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $41,102 - $45,268
-566 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $34,797 - $41,725
566 New
566 $41,000
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $3.59 Million - $4.18 Million
-66,872 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $3.96 Million - $4.63 Million
66,872 New
66,872 $3.96 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $169,824 - $246,793
-3,660 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $123,025 - $160,475
2,500 Added 215.52%
3,660 $234,000
Q3 2019

Nov 20, 2019

BUY
$42.77 - $50.71 $49,613 - $58,823
1,160 New
1,160 $58,000
Q2 2019

Aug 06, 2019

SELL
$44.62 - $49.34 $64,386 - $71,197
-1,443 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $65,108 - $77,633
1,443 New
1,443 $69,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Vestor Capital, LLC Portfolio

Follow Vestor Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestor Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vestor Capital, LLC with notifications on news.